As part of the EU project #VaccinAction2025, the closed-door workshop on 3 December will explore the next frontier of vaccine development. Together with experts and association representatives, we will discuss the main steps in vaccine R&D; innovation and investment priorities, including new platforms (mRNA, DNA) and delivery methods; the return of data to participants and their engagement in research. The initiative is reserved by invitation to leaders of patients’ associations, Patients Advocacy Gropus (PAGs) and Civil Society Organizations (CSOs) already engaged in the ACN’initiatives on the topic. Read more about #VaccinAction2025.